Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 163

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy

Open access
Shiraishi, Yutaka, Fang, Penny, Xu, Cai, Song, Juhee, Krishnan, Sunil, Koay, Eugene J., Mehran, Reza J., Hofstetter, Wayne L., Blum-Murphy, Mariela, Ajani, Jaffer A., Komaki, Ritsuko, Minsky, Bruce, Mohan, Radhe, Hsu, Charles C., Hobbs, Brian P., Lin, Steven H. · 2018 · Radiotherapy and Oncology

Abstract

Background and Purpose Circulating lymphocytes are exquisitely sensitive to radiation exposure, even to low scattered doses which can vary drastically between radiation modalities. We compared the relative risk of radiation-induced lymphopenia between Intensity Modulated Radiation Therapy (IMRT) or Proton Beam Therapy (PBT) in esophageal cancer (EC) patients undergoing neoadjuvant chemoradiation therapy (nCRT). Material and Methods EC patients treated with IMRT and PBT were propensity matched based on key clinical variables. Treatment-associated lymphopenia was graded using CTCAE v.4.0. Using matched cohorts, univariate and multivariable multiple logistic regression was used to identify factors associated with increased risk of grade 4 lymphopenia as well as characterize their relative contributions. Results Among the 480 patients treated with nCRT, 136 IMRT patients were propensity score matched with 136 PBT patients. In the matched groups, a greater proportion of the IMRT patients (55/136, 40.4 %) developed grade 4 lymphopenia during nCRT compared with the PBT patients (24/136, 17.6 %, P < 0.0001). On multivariable analysis, PBT was significantly associated with a reduction in grade 4 lymphopenia risk (odds ratio, 0.29; 95% confidence interval, 0.16 to 0.52; P < 0.0001). Conclusion PBT is associated with significant risk reduction in grade 4 lymphopenia during nCRT in esophageal cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.radonc.2017.11.028

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 163

Metadata

Authors
Shiraishi, Y., Fang, P., Xu, C., Song, J., Krishnan, S., Koay, E. J., Mehran, R. J., Hofstetter, W. L., Blum-Murphy, M., Ajani, J. A., Komaki, R., Minsky, B., Mohan, R., Hsu, C. C., Hobbs, B. P., & Lin, S. H.
Venue
Radiotherapy and Oncology
Publisher
Elsevier BV
Published
2018-07
Volume
128
Issue
1
Pages
154-160
ISSN
0167-8140 (ISSN-L)
OpenAlex
W2775604892
Cited by
163
References
1
FWCI
10.11
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. https://app.cochat.ai/papers/10.1016/j.radonc.2017.11.028
The paper
Shiraishi, Y., Fang, P., Xu, C., Song, J., Krishnan, S., Koay, E. J., Mehran, R. J., Hofstetter, W. L., Blum-Murphy, M., Ajani, J. A., Komaki, R., Minsky, B., Mohan, R., Hsu, C. C., Hobbs, B. P., & Lin, S. H. (2018). Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2017.11.028

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.